RECORD // Company
Faeth Therapeutics, Inc.
Formerly: Sensei Biotherapeutics, Inc.
Built 2026-11-22T05:04:09Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- Faeth Therapeutics, Inc. · the SEC registrant record of this company
Records under a former name (1)
The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.
- Sensei Biotherapeutics, Inc. · Ctgov
Matched by name only, not merged (2)
These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).
- Faeth Therapeutics, Inc. · Ct business · same registered legal name as 'Faeth Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
- Faeth Therapeutics · Ctgov · exact name match to 'Faeth Therapeutics, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
2 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-03 · accession 0001193125-26-444376
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $-20,398,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-03 | 0001193125-26-444376 | 2026-11-22 05:04 UTC | Report an error |
| Cash and cash equivalents | $14,180,000 | at 2026-09-30 | 10-Q | 2026-11-03 | 0001193125-26-444376 | 2026-11-22 05:04 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Revenue, Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001829802
- Ticker
- FTH
- CUSIP
- 81728A207
- Record ID
- sx:sec:0001829802
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
28 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 05:04 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 05:04 UTC | Report an error |
| State of incorporation | DE | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 05:04 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 05:04 UTC | Report an error |
| Business address | 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702 | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 05:04 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 05:04 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-21,085,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-22 05:04 UTC | Report an error |
| Total assets (at 2025-12-31) | $22,902,000 | 2025-12-31 | 10-K, XBRL Assets | 2026-11-22 05:04 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $18,592,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-22 05:04 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $8,668,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 05:04 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-20,453,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 05:04 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $16,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 05:04 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $1,429,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 05:04 UTC | Report an error |
| Form D total offering amount (D filed 2026-03-04) | $348,906,500 | 2026-03-04 | D | 2026-11-22 05:04 UTC | Report an error |
| Form D total amount sold (D filed 2026-03-04) | $348,906,500 | 2026-03-04 | D | 2026-11-22 05:04 UTC | Report an error |
| Form D industry group | Biotechnology | 2026-03-04 | D | 2026-11-22 05:04 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2026-03-04 | D | 2026-11-22 05:04 UTC | Report an error |
| Form D date of first sale | 2026-02-17 | 2026-03-04 | D | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #1 (13F as filed): MONTANOVA CAPITAL, LLC | $50,502,575 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #2 (13F as filed): Avoro Capital Advisors LLC | $36,100,975 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #3 (13F as filed): BAKER BROS. ADVISORS LP | $32,160,275 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #4 (13F as filed): Balyasny Asset Management L.P. | $26,054,950 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #5 (13F as filed): Fairmount Funds Management LLC | $18,050,500 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #6 (13F as filed): Logos Global Management LP | $18,050,500 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #7 (13F as filed): RA CAPITAL MANAGEMENT, L.P. | $18,050,500 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #8 (13F as filed): Vivo Capital, LLC | $18,050,500 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #9 (13F as filed): Caligan Partners LP | $15,736,675 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
| Largest institutional holder #10 (13F as filed): B Group, Inc. | $15,254,225 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:04 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-09 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-11-09 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-03 Filing S-8 filed
- 2026-11-03 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-11-03 Filing 10-Q filed
- 2026-10-27 Filing 8-K filed: Item 5.02 officer or director change
- 2026-09-17 Filing 8-K filed: Item 5.02 officer or director change
- 2026-08-04 Filing 10-Q filed
- 2026-08-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-23 Filing 8-K filed: Item 5.02 officer or director change
- 2026-06-18 Filing 8-K filed: Item 1.01 material agreement; Item 8.01 other event; Item 9.01 exhibits
- 2026-06-18 Filing S-3ASR filed
- 2026-06-15 Filing 8-K filed: Item 1.02 agreement terminated; Item 5.02 officer or director change; Item 5.03 charter or bylaw amendment; Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
- 2026-06-12 Filing EFFECT filed
- 2026-06-10 Filing CORRESP filed
- 2026-06-10 Filing S-3/A filed
- 2026-06-10 Filing 8-K filed: Item 5.02 officer or director change; Item 5.03 charter or bylaw amendment; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-06-02 Filing 10-K/A filed
- 2026-06-02 Filing CORRESP filed
- 2026-06-02 Filing S-3/A filed
- 2026-05-28 Filing UPLOAD filed
- 2026-05-22 Filing DEFA14A filed
- 2026-05-22 Filing 8-K filed: Item 8.01 other event
- 2026-05-21 Filing DEFA14A filed
- 2026-05-21 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No EIN on the SEC filing, so no Form 990 lookup
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T05:04:09Z
- Propublica 990: checked, nothing found · 2026-11-22T05:04:10Z
- SEC 13F holdings: checked · 2026-11-22T05:04:10Z
- USAspending: checked, nothing found · 2026-11-22T05:04:11Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.